Expert: Aducanumab Approval Creates Hope, New Opportunities for Patients with Alzheimer Disease

Video

Pamela Spicer, senior analyst at Datamonitor with Informa Pharma Intelligence, said there are no other currently available treatments for Alzheimer disease that get to the root of the condition.

Although the FDA approval of aducanumab for the treatment of patients with Alzheimer disease and mild cognitive impairment has been debated, Pamela Spicer, senior analyst at Datamonitor with Informa Pharma Intelligence, said its approval is a momentous occasion for this patient population. Spicer said there are no other currently available treatments for Alzheimer disease that get to the root of the disease, so the approval of aducanumab gives patients much-needed hope.

Related Videos
pharmacy oncology, Image Credit: © Konstantin Yuganov - stock.adobe.com
Mayo Clinic oncology pharmacy
Testicular cancer and prostate cancer concept. | Image Credit: kenchiro168 - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Bottle and scattered pills on color background, top view | Image Credit: New Africa - stock.adobe.com
pharmacy | Image Credit: Diego Cervo - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.